These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1732423)

  • 1. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.
    Tirelli U; Zagonel V; Errante D; Serraino D; Talamini R; De Cicco M; Carbone A; Monfardini S
    J Clin Oncol; 1992 Feb; 10(2):228-36. PubMed ID: 1732423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients.
    Tirelli U; Errante D; Spina M; Gastaldi R; Nigra E; Nosari AM; Magnani G; Vaccher E
    Cancer; 1996 May; 77(10):2127-31. PubMed ID: 8640681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.
    Tirelli U; Errante D; Van Glabbeke M; Teodorovic I; Kluin-Nelemans JC; Thomas J; Bron D; Rosti G; Somers R; Zagonel V; Noordijk EM
    J Clin Oncol; 1998 Jan; 16(1):27-34. PubMed ID: 9440719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy specifically devised for elderly patients with unfavorable non-Hodgkin's lymphoma.
    Zagonel V; Tirelli U; Carbone A; Errante D; Morassot S; Sorio R; Monfardini S
    Cancer Invest; 1990; 8(6):577-82. PubMed ID: 2292050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone in combination with etoposide and prednimustine in patients older than 70 years with unfavorable non-Hodgkin's lymphoma: a prospective study in 52 patients.
    Tirelli U; Zagonel V; Sorio R; Errante D; Talamini R; Carbone A; Monfardini S
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):13-22. PubMed ID: 8073302
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of low-grade non-Hodgkin's lymphoma by cytoreductive chemotherapy with prednimustine/mitoxantrone followed by interferon alpha-2b maintenance: results of a clinical phase II study.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; van de Loo J
    Semin Oncol; 1990 Dec; 17(6 Suppl 10):20-3. PubMed ID: 2259919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.
    Morra E; Gargantini L; Nosari A; Barbarano L; Pungolino E; Santoleri L; Bernuzzi P
    Crit Rev Oncol Hematol; 2000 Aug; 35(2):95-100. PubMed ID: 10936466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patients.
    Tirelli U; Carbone A; Zagonel V; Veronesi A; Canetta R
    Eur J Cancer Clin Oncol; 1987 May; 23(5):535-40. PubMed ID: 3653177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy.
    Sonneveld P; de Ridder M; van der Lelie H; Nieuwenhuis K; Schouten H; Mulder A; van Reijswoud I; Hop W; Lowenberg B
    J Clin Oncol; 1995 Oct; 13(10):2530-9. PubMed ID: 7595704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma.
    Yau JC; Germond C; Gluck S; Cripps C; Verma S; Burns BF; Koski TM; Lister DC; Goss GD
    Am J Hematol; 1998 Oct; 59(2):156-60. PubMed ID: 9766801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).
    Zinzani PL; Tani M; Pulsoni A; Gobbi M; Perotti A; De Luca S; Fabbri A; Zaccaria A; Voso MT; Fattori P; Guardigni L; Ronconi S; Cabras MG; Rigacci L; De Renzo A; Marchi E; Stefoni V; Fina M; Pellegrini C; Musuraca G; Derenzini E; Pileri S; Fanti S; Piccaluga PP; Baccarani M
    Lancet Oncol; 2008 Apr; 9(4):352-8. PubMed ID: 18342572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: identification of two age subgroups with differing hematologic toxicity.
    Gómez H; Mas L; Casanova L; Pen DL; Santillana S; Valdivia S; Otero J; Rodriguez W; Carracedo C; Vallejos C
    J Clin Oncol; 1998 Jul; 16(7):2352-8. PubMed ID: 9667250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide, mitoxantrone and prednisone: a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin's lymphoma.
    Doorduijn JK; Spruit P; van Der Holt B; van't Veer M; Budel L; Löwenberg B; Sonneveld P
    Haematologica; 2000 Aug; 85(8):814-9. PubMed ID: 10942927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimen.
    Gregory SA; Vose J; Modiano M; Kraemer K; Rifkin R; Rubin A; Menduni T; Ghalie R
    Leuk Lymphoma; 2001 Jan; 40(3-4):315-24. PubMed ID: 11426553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.
    Martelli M; Guglielmi C; Coluzzi S; Avvisati G; Amadori S; Giovannini M; Torromeo C; Mandelli F
    J Clin Oncol; 1993 Dec; 11(12):2362-9. PubMed ID: 7504091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
    De Lena M; Ditonno P; Lorusso V; Brandi M; Timurian A; Marzullo F; Ventrella V; Pellecchia A
    J Clin Oncol; 1995 Apr; 13(4):953-60. PubMed ID: 7535844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma.
    Salvagno L; Contu A; Bianco A; Endrizzi L; Schintu GM; Olmeo N; Aversa SM; Chiarion-Sileni V; Sorarù M; Fiorentino MV
    Ann Oncol; 1992 Dec; 3(10):833-7. PubMed ID: 1286045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized study.
    Takagi T; Sampi K; Sawada U; Sakai C; Oguro M
    Int J Hematol; 1993 Jan; 57(1):67-71. PubMed ID: 8477064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha Interferon maintenance therapy in patients with low-grade non-Hodgkin's lymphomas after cytoreductive chemotherapy with prednimustine and mitoxantrone.
    Hiddemann W; Unterhalt M; Koch P; Nahler M; Herrmann R; van de Loo J
    Eur J Cancer; 1991; 27 Suppl 4():S37-9. PubMed ID: 1799474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.